KVUE: Kenvue Company Aggregate Debts

Symbol and logo of brand Kenvue Inc (KVUE)

Kenvue Inc. (KVUE) relies on long-term loyalty to core pharmacy products that generate a stable cash flow. The leverage level on the GURU.Markets chart confirms a financial strategy where 8.88 serves as the final level marker. The business is based on the habit of families using iconic care brands, while growth efficiency is supported by warehouse robotization and the implementation of AI in logistics chains.

Kenvue Inc. - KVUE Company Debts (period 02/21/2024 - 10/28/2026)
Original product of Kenvue Inc

For Kenvue Inc. (KVUE), with its global distribution of consumer goods, the volume of raised funds reflects a balance between expansion and financial stability. This indicator aggregates all short-term and long-term liabilities, determining the total credit load. The total amount of borrowed funds allows for an assessment of default risk in the event of a decline in demand. An optimal debt level provides the resources necessary for scaling production, while low debt dependency confirms the high resilience of the business.

Analysis of competing companies

Aggregate Debt Obligations Haleon Corp (HLN)|Company Aggregate Debts VRNA (Verona Pharma plc)|jyongbio.com - Company Aggregate Debts|Company Debts Ligand (LGND)|AMRX: Aggregate Debt Obligations|PRGO (Perrigo Company) - Company Debts|Alvotech Biopharmaceuticals (ALVO) - Company Total Debt|LQDA (Liquidia Corporation) - Company Aggregate Debts|Company Aggregate Debts glpg.com (GLPG)|ANI Pharmaceuticals, Inc. (ANIP) - Company Total Debt|Aggregate Debt Obligations MNKD (MannKind Corp)|AMPH: Company Debts|PCRX - Company Cumulative Debt|Company Total Debt ARS Pharmaceuticals SPRY|TBPH - Company Cumulative Indebtedness|Company Aggregate Debts Aquestive Therapeutics, Inc. AQST|scPharmaceuticals (SCPH) - Aggregate Debt Obligations|Company Aggregate Debts TECX (Tectonic Therapeutic Inc.)|Company Cumulative Debt TNXP|China SXT Pharmaceuticals (SXTC) - Company Debts|Aggregate Debt Obligations EPRX (eupraxiapharma.com)|Company Debts BHST (BioHarvest Sciences Inc.)|Company Aggregate Debts Invizyne Technologies EXOZ|ORMP (Oramed Pharma) - Company Aggregate Debts|ENTX: Company Cumulative Debt|Company Debts MindWalk Holdings|Company Aggregate Debt abvcpharma.com|Company Total Debt Cumberland Pharmaceuticals Inc.|Company Debts Quantum BioPharma Ltd. (QNTM)|Company Total Debt FGEN|Company Aggregate Debts Telomir Pharmaceuticals Corp (TELO)|RANI: Company Aggregate Debts|SNYR - Company Cumulative Debt|Company Total Debt Rallybio Corp. (RLYB)|LEXX - Aggregate Debt Obligations|Pulmatrix Corp - Company Aggregate Debts|PTHL (Pheton Holdings) - Company Total Debt Obligations|Company Debts Aptorum Group Ltd (APM)|Company Aggregate Debt lyratherapeutics.com|Company Aggregate Debts IBO (Impact BioMedical)|Company Total Debt tnfpharma.com TNFA|Company Total Debt YCBD|PainReform Corp - Company Total Debt Obligations|Auris Medical - Company Debts|lipella.com (LIPO) - Company Aggregate Debts|OptiNose (OPTN) - Company Total Debt|Company Debts Pieris Pharmaceuticals Inc|PROC (Procaps Group SA) - Company Total Debt|Company Aggregate Debts Petros Pharma|Qilian International - Company Aggregate Debts|Company Cumulative Debt SLRN (acelyrin.com)|TFF Pharmaceuticals, Inc. (TFFP) - Company Debts